APG808 resulted in a rapid and durable decrease from baseline in FeNO and pSTAT6 measurements throughout the 12 weeks.

Biogenetics company Klotho Neurosciences has announced plans to acquire certain assets from Turn Biotechnologies.

Star Therapeutics has completed a Series D funding round, raising $125m, aimed at supporting its pipeline progression.

Johnson & Johnson's Tremfya is the first IL-23 inhibitor to gain FDA approval in a paediatric population for plaque psoriasis ...

Changing trends in the biopharma sector may mean new risks for established players and opportunities for growth, says BIA ...

As CF treatment duration extends, registry-based analyses will need to track pathogen-specific trends and long-term disease ...

NewCo’ licensing of clinical candidates is allowing Chinese biotechs to offload costs while expanding profits on a global ...

Oral liquid drugs play a vital role for patients who have difficulty swallowing tablets and for those requiring personalised ...

Genmab has signed an agreement to buy all shares of Merus at $97 per share, in an all-cash transaction valued at $8bn.

The US FDA has expanded the approval of Regeneron Pharmaceuticals' fully human monoclonal antibody, Evkeeza (evinacumab-dgnb) ...

Amgen has revealed a significant investment plan, earmarking $650m to enhance its manufacturing operations in the US.